S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
U.S. Military Defense Fails Without Vanadium? (Ad)
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
U.S. Military Defense Fails Without Vanadium? (Ad)
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
U.S. Military Defense Fails Without Vanadium? (Ad)
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
U.S. Military Defense Fails Without Vanadium? (Ad)
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts

Surmodics Stock Price, News & Analysis (NASDAQ:SRDX)

$33.64
+0.25 (+0.75%)
(As of 12/4/2023 ET)
Compare
Today's Range
$32.93
$34.01
50-Day Range
$28.47
$35.09
52-Week Range
$16.00
$39.41
Volume
42,184 shs
Average Volume
107,834 shs
Market Capitalization
$476.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$57.50

Surmodics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
70.9% Upside
$57.50 Price Target
Short Interest
Healthy
1.73% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.52
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.00) to ($0.29) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.22 out of 5 stars

Medical Sector

332nd out of 952 stocks

Surgical & Medical Instruments Industry

39th out of 89 stocks


SRDX stock logo

About Surmodics Stock (NASDAQ:SRDX)

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

SRDX Stock Price History

SRDX Stock News Headlines

New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
See More Headlines
Receive SRDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surmodics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
12/05/2023
Next Earnings (Estimated)
2/05/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:SRDX
CUSIP
86887310
Employees
376
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$57.50
High Stock Price Target
$71.00
Low Stock Price Target
$44.00
Potential Upside/Downside
+70.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-1,540,000.00
Pretax Margin
1.88%

Debt

Sales & Book Value

Annual Sales
$132.58 million
Cash Flow
$0.79 per share
Book Value
$8.48 per share

Miscellaneous

Free Float
13,094,000
Market Cap
$476.21 million
Optionable
Optionable
Beta
1.15

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report














SRDX Stock Analysis - Frequently Asked Questions

Should I buy or sell Surmodics stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Surmodics in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SRDX shares.
View SRDX analyst ratings
or view top-rated stocks.

What is Surmodics' stock price target for 2024?

2 brokers have issued 1 year price targets for Surmodics' stock. Their SRDX share price targets range from $44.00 to $71.00. On average, they expect the company's share price to reach $57.50 in the next year. This suggests a possible upside of 70.9% from the stock's current price.
View analysts price targets for SRDX
or view top-rated stocks among Wall Street analysts.

How have SRDX shares performed in 2023?

Surmodics' stock was trading at $34.12 on January 1st, 2023. Since then, SRDX stock has decreased by 1.4% and is now trading at $33.64.
View the best growth stocks for 2023 here
.

Are investors shorting Surmodics?

Surmodics saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 235,300 shares, an increase of 71.0% from the October 31st total of 137,600 shares. Based on an average trading volume of 63,100 shares, the days-to-cover ratio is currently 3.7 days. Approximately 1.7% of the shares of the stock are short sold.
View Surmodics' Short Interest
.

When is Surmodics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 5th 2024.
View our SRDX earnings forecast
.

How were Surmodics' earnings last quarter?

Surmodics, Inc. (NASDAQ:SRDX) released its earnings results on Wednesday, November, 8th. The company reported $0.53 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.37. The company had revenue of $27.97 million for the quarter, compared to analyst estimates of $26 million. Surmodics had a negative net margin of 1.16% and a positive trailing twelve-month return on equity of 1.99%.

What ETF holds Surmodics' stock ?

Invesco Nasdaq Future Gen 200 ETF holds 1,909 shares of SRDX stock, representing 0.85% of its portfolio.

What guidance has Surmodics issued on next quarter's earnings?

Surmodics issued an update on its FY 2024 earnings guidance on Wednesday, November, 8th. The company provided earnings per share guidance of -$1.32--$0.97 for the period, compared to the consensus estimate of -$0.20. The company issued revenue guidance of $112.00 million-$117.00 million, compared to the consensus revenue estimate of $130.88 million.

What is Gary Maharaj's approval rating as Surmodics' CEO?

8 employees have rated Surmodics Chief Executive Officer Gary Maharaj on Glassdoor.com. Gary Maharaj has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Surmodics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surmodics investors own include Gilead Sciences (GILD), Netflix (NFLX), Exelixis (EXEL), Intel (INTC), NVIDIA (NVDA), Tandem Diabetes Care (TNDM), uniQure (QURE), Sangamo Therapeutics (SGMO), Abbott Laboratories (ABT) and Dynavax Technologies (DVAX).

Who are Surmodics' major shareholders?

Surmodics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Acadian Asset Management LLC (2.51%), Kennedy Capital Management LLC (1.63%), Jacobs Levy Equity Management Inc. (0.99%), Northern Trust Corp (0.97%), Salem Investment Counselors Inc. (0.91%) and Charles Schwab Investment Management Inc. (0.78%). Insiders that own company stock include Charles W Olson, Charles W Olson, David Dantzker, Gary R Maharaj, John D Manders, Jose H Bedoya, Jose H Bedoya, Joseph J Stich, Joseph J Stich and Ronald B Sr Kalich Sr.
View institutional ownership trends
.

How do I buy shares of Surmodics?

Shares of SRDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SRDX) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -